Cargando…
Synergistic antitumor effect of 5-fluorouracil with the novel LSD1 inhibitor ZY0511 in colorectal cancer
BACKGROUND: Lysine-specific histone demethylase 1 (LSD1) is a potential target of cancer therapy. In the present study, we aimed to investigate the combined antitumor activity of a novel LSD1 inhibitor (ZY0511) with 5-fluorouracil (5-FU) and elucidate the underlying mechanism in colorectal cancer (C...
Autores principales: | Peng, Wen, Zhang, Huaqing, Tan, Shisheng, Li, Yan, Zhou, Yang, Wang, Liang, Liu, Chunqi, Li, Qiu, Cen, Xiaobo, Yang, Shengyong, Zhao, Yinglan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378962/ https://www.ncbi.nlm.nih.gov/pubmed/32754230 http://dx.doi.org/10.1177/1758835920937428 |
Ejemplares similares
-
The novel LSD1 inhibitor ZY0511 suppresses diffuse large B-cell lymphoma proliferation by inducing apoptosis and autophagy
por: Liu, Huan, et al.
Publicado: (2021) -
Lipidomic profiling reveals lipid regulation by a novel LSD1 inhibitor treatment
por: Li, Yan, et al.
Publicado: (2021) -
Synergistic Antitumor Effect of Dichloroacetate in Combination with 5-Fluorouracil in Colorectal Cancer
por: Tong, Jingtao, et al.
Publicado: (2011) -
Campylobacter jejuni gene cj0511 encodes a serine peptidase essential for colonisation
por: Karlyshev, A.V., et al.
Publicado: (2014) -
Pharmacological inhibition of LSD1 suppresses growth of hepatocellular carcinoma by inducing GADD45B
por: Sang, Na, et al.
Publicado: (2023)